Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProLYOtin
- Development stage
- Unknown
- Lead developer
- Pro-Bio
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
ProLYOtin is a lyophilized whey protein isolate (WPI) specifically formulated for enhanced palatability compared to standard whey proteins. It is primarily investigated for its antioxidant, anti-inflammatory, and metabolic benefits in populations with obesity, overweight, and type 2 diabetes mellitus (DM2). The supplement works by increasing the activity of antioxidant enzymes such as glutathione peroxidase and reducing levels of uric acid, which is often elevated in metabolic syndrome. Clinical studies have demonstrated that daily supplementation with 40g of ProLYOtin over 12 weeks can lead to significant improvements in body composition, specifically reducing fat mass and improving anthropometric parameters, without adverse effects on glycemic markers or blood pressure. It is developed by Pro-Bio srl.
- Brand names
- ProLYOtin
- Other names
- whey protein isolate
02
Targets
GPX4 (Glutathione peroxidase 4)
Beyond the preview
Go deeper on ProLYOtin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProLYOtin.